Basic information |
Metabolite name | Sebacic acid |
HMDB0000792 | |
C08277 | |
5192 | |
Synonyms | Sebacate |
No. of studies | 8 |
Relationship between Sebacic acid and depression (count: 8) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M006 | Type1 | depressed group vs. control group | Plasma | Human | Up |
Study M1019 | Type1 | depression group vs. control group | Serum | Human | Up |
Study M1024 | Type1 | CUMS group vs. control group | CA3 region of hippocampus | ICR mouse | Down |
Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
Study M1024 | Type1 | CUMS group vs. control group | DG region of hippocampus | ICR mouse | Down |
Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | DG region of hippocampus | ICR mouse | Up |
Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA3 region of hippocampus | ICR mouse | Up |
Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | CA1 region of hippocampus | ICR mouse | Up |
Study M1090 | Type1 | CUMS group vs. control group | Plasma | BALb/c mouse | Up |
Study M114 | Type3 | venlafaxine group vs. control group | Astrocyte | Sprague-Dawley rat | Up |
Study M207 | Type1 | depressed group vs. control group | Serum | Kunming mouse | Down |
Study M715 | Type1 | MDD group vs. control group | Faece | Human | Up |
Study M827 | Type1 | CUMS group vs. control group | Urine | Sprague-Dawley rat | Up |
Study M827 | Type1 | CUMS + high dose of Millettia speciosa Champ group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
Study M827 | Type1 | CUMS + low dose of Millettia speciosa Champ group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
Study M827 | Type1 | CUMS + middle dose of Millettia speciosa Champ group vs. CUMS group | Urine | Sprague-Dawley rat | Down |
Study M827 | Type1 | CUMS + fluoxetine group vs. CUMS group | Urine | Sprague-Dawley rat | Down |